Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes.
|
Aug 2012
|
Blood
|
myelodysplastic syndromes (MDS)
|
Historical perspectives on myelodysplastic syndromes
|
Aug 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Rationale for the Clinical Application of Flow Cytometry in Patients with Myelodysplastic Syndromes
|
Aug 2012
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
Molecular Pathophysiology of Myelodysplastic Syndromes.
|
Aug 2012
|
Annu Rev Pathol
|
myelodysplastic syndromes (MDS)
|
Serial assessment of suspected myelodysplastic syndromes: significance of flow cytometric findings validated by cytomorphology, cytogenetics, and molecular genetics
|
Aug 2012
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
The Race for Survival in Myelodysplastic Syndromes
|
Sep 2012
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
New therapeutics for myelodysplastic syndromes
|
Sep 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Expression of DLK1 Gene in the Bone Marrow Cells of Patients with Myelodysplastic Syndromes and Its Clinical Significance.
|
Sep 2012
|
Cancer Biol Med
|
myelodysplastic syndromes (MDS)
|
Molecular genetics in myelodysplastic syndromes
|
Sep 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Dysplasia Has A Differential Diagnosis: Distinguishing Genuine Myelodysplastic Syndromes (MDS) From Mimics, Imitators, Copycats and Impostors
|
Sep 2012
|
Curr Hematol Malig Rep
|
myelodysplastic syndromes (MDS)
|